Consider current large-scale practices for oligonucleotide synthesis as a basis for improving commercial-scale platform strategies.
Bill Jarvis
Advertisement
Bill Jarvis is process engineer and senior associate at CRB.
Articles by Bill Jarvis
Advertisement
Latest Updated Articles
Designing Commercial-Scale Oligonucleotide SynthesisPublished: February 2nd 2020 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
PharmTech Weekly News Roundup – Week of November 3, 2025
4
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
5
